Opinion|Videos|April 4, 2025
Implementation Barriers
Experts discuss the most significant barriers to continuous glucose monitoring (CGM) implementation encountered in their respective roles and how these barriers vary across different patient populations and care settings.
Advertisement
Episodes in this series
Video content above is prompted by the following:
What are the most significant barriers to CGM implementation you've encountered in your respective roles?
How do these barriers vary across different patient populations and care settings?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Amid SOHO Data, Reviewers of BTK Inhibitors in MCL Call for Trials
4
Counseling Vitiligo Patients on Time to Repigmentation
5